PharmiWeb.com - Global Pharma News & Resources
31-Aug-2022

Zur Rose Group launches approx. CHF 100 million Convertible Bonds and approx. CHF 50 million Capital Increase by way of an accelerated book building process

Zur Rose Group AG / Key word(s): Corporate Action

31-Aug-2022 / 17:41 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Please find our press release about a capital measure under the following link:
https://zurrosegroup.com/websites/zurrosegroup/English/204020/financing.html
 

End of Inside Information
Language: English
Company: Zur Rose Group AG
Walzm├╝hlestrasse 60
8500 Frauenfeld
Switzerland
Phone: +41 52 724 08 14
Internet: www.zurrosegroup.com
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 1432735

 
End of Announcement EQS News Service

Editor Details

Last Updated: 31-Aug-2022